Cancer-related anemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The population with tumor diagnosed by histopathology or cytology; (2) People diagnosed with anemia (see Table 1 for the diagnostic criteria of anemia); (3) Karnofsky Performance Status score is above 70. (4) The estimated survival time is > 3 months. (5) 18 = age = 80 years when signing the informed consent. (6) Voluntarily sign informed consent
Exclusion criteria
Exclusion criteria: (1) Other clinical trials are currently underway; (2) Women who are breastfeeding, pregnant, or planning to become pregnant; (3) Those who are known to be allergic to Zaizaoshengxue Capsules or its contained ingredients; (4) Participated in other drug clinical trials within one month before enrollment. (5) Having taken similar proprietary Chinese medicines or traditional Chinese medicine decoctions within one month before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin content;syndrome points; | — |
Secondary
| Measure | Time frame |
|---|---|
| Red blood cell count;Hematocrit;Mean Corpuscular Volume; Red Cell Distribution Width;White blood cell count;Lymphocyte Count;Neutrophil Count;platelet count;Plateletcrit ;Mean Platelet Volume;Single syndrome points; | — |
Countries
china
Contacts
Longhua Hospital Shanghai University of Traditional Chinese Medicine